Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 16 Dec 2025 for Traws Pharma, Inc..
Insider track record
Disclosed buys
0
Disclosed sells
0
Signal history
No signal scores available.
John Harold Leaman: trading record in brief
John Harold Leaman has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Impel Neuropharma Inc and Traws Pharma, Inc. Over a trading history stretching from 31 December 2022 to 12 December 2025, the count stands at 3 filings.
Not one of the filings records a straightforward purchase or sale on the market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The newest entry dates from 16 December 2025: a share grant, in Traws Pharma, Inc. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to John Harold Leaman
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations3 total
4,058 shares0Common StockSEC:0001586657-25-000008:0
3,627 shares@ US$3.75100.0% of flowCommon StockSEC:0001209191-23-001365:1
10,571 shares0Common StockSEC:0001209191-23-001365:0
3 of 3 declarations
